01-06-2019 | Research Article
Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety
Published in: Frontiers of Medicine | Issue 3/2019
Login to get access01-06-2019 | Research Article
Published in: Frontiers of Medicine | Issue 3/2019
Login to get access